210 related articles for article (PubMed ID: 23451094)
1. High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma.
Bancos I; Bida JP; Tian D; Bundrick M; John K; Holte MN; Her YF; Evans D; Saenz DT; Poeschla EM; Hook D; Georg G; Maher LJ
PLoS One; 2013; 8(2):e56827. PubMed ID: 23451094
[TBL] [Abstract][Full Text] [Related]
2. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
Smith EH; Janknecht R; Maher LJ
Hum Mol Genet; 2007 Dec; 16(24):3136-48. PubMed ID: 17884808
[TBL] [Abstract][Full Text] [Related]
3. A suppressor of dioxygenase inhibition in a yeast model of SDH deficiency.
Beimers W; Braun M; Schwinefus K; Pearson K; Wilbanks B; Maher LJ
Endocr Relat Cancer; 2022 May; 29(6):345-358. PubMed ID: 35315791
[TBL] [Abstract][Full Text] [Related]
4. Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma.
Dwight T; Na U; Kim E; Zhu Y; Richardson AL; Robinson BG; Tucker KM; Gill AJ; Benn DE; Clifton-Bligh RJ; Winge DR
BMC Cancer; 2017 Jul; 17(1):497. PubMed ID: 28738844
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect.
Moosavi B; Zhu XL; Yang WC; Yang GF
Eur J Cell Biol; 2020 Jan; 99(1):151057. PubMed ID: 31810635
[TBL] [Abstract][Full Text] [Related]
6. Functional study in a yeast model of a novel succinate dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor.
Goffrini P; Ercolino T; Panizza E; Giachè V; Cavone L; Chiarugi A; Dima V; Ferrero I; Mannelli M
Hum Mol Genet; 2009 May; 18(10):1860-8. PubMed ID: 19261679
[TBL] [Abstract][Full Text] [Related]
7. The SDHB Arg230His mutation causing familial paraganglioma alters glycolysis in a new
Saskői É; Hujber Z; Nyírő G; Likó I; Mátyási B; Petővári G; Mészáros K; Kovács AL; Patthy L; Supekar S; Fan H; Sváb G; Tretter L; Sarkar A; Nazir A; Sebestyén A; Patócs A; Mehta A; Takács-Vellai K
Dis Model Mech; 2020 Oct; 13(10):. PubMed ID: 32859697
[TBL] [Abstract][Full Text] [Related]
8. Instability of succinate dehydrogenase in SDHD polymorphism connects reactive oxygen species production to nuclear and mitochondrial genomic mutations in yeast.
Chang YL; Hsieh MH; Chang WW; Wang HY; Lin MC; Wang CP; Lou PJ; Teng SC
Antioxid Redox Signal; 2015 Mar; 22(7):587-602. PubMed ID: 25328978
[TBL] [Abstract][Full Text] [Related]
9. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
10. Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism.
Lussey-Lepoutre C; Hollinshead KE; Ludwig C; Menara M; Morin A; Castro-Vega LJ; Parker SJ; Janin M; Martinelli C; Ottolenghi C; Metallo C; Gimenez-Roqueplo AP; Favier J; Tennant DA
Nat Commun; 2015 Nov; 6():8784. PubMed ID: 26522426
[TBL] [Abstract][Full Text] [Related]
11. Rare presentation of familial paraganglioma without evidence of mutation in the SDH, RET and VHL genes: towards further genetic heterogeneity.
Persu A; Amyere M; Gutierrez-Roelens I; Rustin P; Sempoux C; Lecouvet FE; Van Beers BE; Horsmans Y; De Plaen JF; MarcHamoir ; Vikkula M
J Hypertens; 2009 Jan; 27(1):76-82. PubMed ID: 19145771
[TBL] [Abstract][Full Text] [Related]
12. On the association of succinate dehydrogenase mutations with hereditary paraganglioma.
Baysal BE
Trends Endocrinol Metab; 2003 Dec; 14(10):453-9. PubMed ID: 14643060
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis.
Ricci L; Stanley FU; Eberhart T; Mainini F; Sumpton D; Cardaci S
Cell Death Dis; 2023 Jul; 14(7):403. PubMed ID: 37414778
[TBL] [Abstract][Full Text] [Related]
14. SDHA is a tumor suppressor gene causing paraganglioma.
Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
[TBL] [Abstract][Full Text] [Related]
16. Model systems in SDHx-related pheochromocytoma/paraganglioma.
Takács-Vellai K; Farkas Z; Ősz F; Stewart GW
Cancer Metastasis Rev; 2021 Dec; 40(4):1177-1201. PubMed ID: 34957538
[TBL] [Abstract][Full Text] [Related]
17. Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome.
Panizza E; Ercolino T; Mori L; Rapizzi E; Castellano M; Opocher G; Ferrero I; Neumann HP; Mannelli M; Goffrini P
Hum Mol Genet; 2013 Feb; 22(4):804-15. PubMed ID: 23175444
[TBL] [Abstract][Full Text] [Related]
18. Oxygen concentration controls epigenetic effects in models of familial paraganglioma.
Her YF; Nelson-Holte M; Maher LJ
PLoS One; 2015; 10(5):e0127471. PubMed ID: 25985299
[TBL] [Abstract][Full Text] [Related]
19. The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.
Bayley JP; Grimbergen AE; van Bunderen PA; van der Wielen M; Kunst HP; Lenders JW; Jansen JC; Dullaart RP; Devilee P; Corssmit EP; Vriends AH; Losekoot M; Weiss MM
BMC Med Genet; 2009 Apr; 10():34. PubMed ID: 19368708
[TBL] [Abstract][Full Text] [Related]
20. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
